Wed, October 5, 2022
Tue, October 4, 2022
Mon, October 3, 2022
Sun, October 2, 2022
Fri, September 30, 2022
Thu, September 29, 2022
Wed, September 28, 2022
Tue, September 27, 2022
Mon, September 26, 2022
Fri, September 23, 2022

David Risinger Maintained (ABBV) at Sell with Decreased Target to $135 on, Sep 30th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-decreased-target-to-135-on-sep-30th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

David Risinger of SVB Leerink, Maintained "AbbVie Inc." (ABBV) at Sell with Decreased Target from $140 to $135 on, Sep 30th, 2022.

David has made no other calls on ABBV in the last 4 months.



There are 11 other peers that have a rating on ABBV. Out of the 11 peers that are also analyzing ABBV, 5 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Carter Gould of "Barclays" Maintained at Hold with Decreased Target to $160 on, Monday, August 1st, 2022
  • Colin Bristow of "UBS" Maintained at Hold with Decreased Target to $146 on, Monday, August 1st, 2022
  • Steve Chesney of "Atlantic Equities" Maintained at Hold with Decreased Target to $162 on, Monday, August 1st, 2022
  • Luisa Hector of "Berenberg" Reiterated at Hold and Held Target at $135 on, Friday, July 15th, 2022
  • Geoff Meacham of "B of A Securities" Reiterated at Hold and Held Target at $156 on, Tuesday, June 21st, 2022


These are the ratings of the 6 analyists that currently disagree with David


  • Terence Flynn of "Morgan Stanley" Reiterated at Buy and Held Target at $188 on, Wednesday, September 14th, 2022
  • Jasper Hellweg of "Argus Research" Maintained at Strong Buy with Decreased Target to $155 on, Wednesday, August 24th, 2022
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $188 on, Monday, August 1st, 2022
  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Decreased Target to $155 on, Monday, August 1st, 2022
  • Gary Nachman of "BMO Capital" Maintained at Buy with Decreased Target to $170 on, Monday, August 1st, 2022
  • Robyn Karnauskas of "Truist Securities" Reiterated at Strong Buy and Held Target at $160 on, Friday, July 29th, 2022

Publication Contributing Sources